Variant report
Variant | nsv824289 |
---|---|
Chromosome Location | chr7:119395751-119398248 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:119397490..119400025-chr7:119421872..119424720,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578079527 | chr7:119395753-119395754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545677701 | chr7:119395855-119395856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140375825 | chr7:119395860-119395861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181711192 | chr7:119395908-119395909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548442636 | chr7:119395984-119395985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568269641 | chr7:119395988-119395989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116360648 | chr7:119396041-119396042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10264773 | chr7:119396089-119396090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11543743 | chr7:119396096-119396097 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs62477387 | chr7:119396126-119396127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11536523 | chr7:119396134-119396135 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs539486585 | chr7:119396150-119396151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184668741 | chr7:119396184-119396185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576376370 | chr7:119396190-119396191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542010638 | chr7:119396222-119396223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555499950 | chr7:119396291-119396292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575177641 | chr7:119396323-119396324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572308826 | chr7:119396349-119396350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79836113 | chr7:119396352-119396353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562703890 | chr7:119396370-119396371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77168884 | chr7:119396413-119396414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374783302 | chr7:119396441-119396442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189457954 | chr7:119396448-119396449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377633433 | chr7:119396452-119396453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78935602 | chr7:119396455-119396456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531595052 | chr7:119396477-119396478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143662105 | chr7:119396483-119396484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548504146 | chr7:119396505-119396506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180758188 | chr7:119396513-119396514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568230978 | chr7:119396526-119396527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549115150 | chr7:119396546-119396547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374408815 | chr7:119396548-119396549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527501503 | chr7:119396605-119396606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547857709 | chr7:119396623-119396624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561640792 | chr7:119396640-119396641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138683249 | chr7:119396666-119396667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78680761 | chr7:119396683-119396684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs116862835 | chr7:119396716-119396717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185837713 | chr7:119396719-119396720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191082743 | chr7:119396811-119396812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146043544 | chr7:119396816-119396817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535704342 | chr7:119396827-119396828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369747690 | chr7:119396829-119396830 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555662087 | chr7:119396932-119396933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572288499 | chr7:119396972-119396973 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112065383 | chr7:119396985-119396986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553827298 | chr7:119397034-119397035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6946759 | chr7:119397052-119397053 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs34651892 | chr7:119397178-119397179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533072322 | chr7:119397217-119397218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:119364800-119416000 | Weak transcription | K562 | blood |
2 | chr7:119393400-119396800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr7:119393400-119396800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:119393400-119397000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr7:119393600-119395800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr7:119395000-119396000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr7:119395000-119396000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr7:119395200-119396400 | Weak transcription | H1 Cell Line | embryonic stem cell |
9 | chr7:119395400-119395800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr7:119395600-119397000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr7:119395800-119396400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr7:119395800-119396800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr7:119396000-119396400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr7:119396000-119397200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr7:119396400-119397000 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr7:119396800-119400400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
17 | chr7:119397000-119397200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |